US Patent Issued to NEC on Nov. 4 for "Method and system of targeting epitopes for neoantigen-based immunotherapy" (Japanese, German Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,462,897, issued on Nov. 4, was assigned to NEC Corp. (Tokyo).

"Method and system of targeting epitopes for neoantigen-based immunotherapy" was invented by Brandon Malone (Dossenheim, Germany), Kousuke Onoue (Kanagawa, Japan) and Yoshiko Yoshihara (Kanagawa, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of ranking epitopes derived from neoantigens as targets for personalized immunotherapy includes collecting candidate epitopes based on patient data of a cancer patient. A set of scores are calculated for each of the candidate epitopes, each of the scores in a respective one of the sets for a respective one of the candidate epitopes represen...